market, with projections indicating 30 million users by 2030 and sales exceeding $1 billion, underlining the critical stakes for both the pharmaceutical industry and individuals claiming harm from these drugs
All PlexusDx medications come from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade purity and sterility equivalent to branded injectables
Lastly, there is variability in individual responses to AOMs, although when paired with lifestyle changes, these medications generally lead to significantly more weight loss compared to placebo
NAC, or N-acetylcysteine, is a supplement form of the amino acid cysteine
These results suggest that tirzepatide alone may provide sufficient weight loss for many patients, potentially obviating the need for combination therapy